{"id":"anti-tnf-therapy-including-infliximab","safety":{"commonSideEffects":[{"rate":"10%","effect":"Injection site reaction"},{"rate":"10%","effect":"Headache"},{"rate":"10%","effect":"Fatigue"},{"rate":"5%","effect":"Nausea"},{"rate":"5%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Infliximab is a chimeric monoclonal antibody that selectively binds to human TNF-alpha, thereby inhibiting its interaction with cell surface TNF receptors. This action prevents the inflammatory cascade initiated by TNF-alpha and reduces inflammation in the body.","oneSentence":"Blocks tumor necrosis factor-alpha (TNF-alpha) by binding to it and preventing it from interacting with cell surface TNF receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:10:23.764Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid Arthritis"},{"name":"Psoriatic Arthritis"},{"name":"Ulcerative Colitis"},{"name":"Crohn's Disease"}]},"trialDetails":[{"nctId":"NCT00606346","phase":"","title":"A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Biotech, Inc.","startDate":"2007-05-31","conditions":"Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis","enrollment":4970},{"nctId":"NCT07344428","phase":"NA","title":"Efficacy and Safety of CDED With Anti-TNF-α Biologics in Crohn's Disease: A Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2026-02-01","conditions":"Crohn's Disease；Mucosal Healing；Dietary Intervention","enrollment":185},{"nctId":"NCT07041112","phase":"","title":"Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors","status":"COMPLETED","sponsor":"Juan Ruano Ruiz","startDate":"2012-01-01","conditions":"Psoriasis, Psoriatic Arthritis (PsA), Cardiovascular Risk Factors","enrollment":1000},{"nctId":"NCT04571697","phase":"","title":"A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-28","conditions":"Dementia, Alzheimer Disease","enrollment":34647},{"nctId":"NCT04118556","phase":"PHASE2","title":"Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT","status":"RECRUITING","sponsor":"Mats Remberger","startDate":"2021-12-01","conditions":"GVHD, Acute","enrollment":50},{"nctId":"NCT02557308","phase":"","title":"An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis","status":"TERMINATED","sponsor":"Celltrion","startDate":"2015-05-26","conditions":"Ankylosing Spondylitis","enrollment":329},{"nctId":"NCT02557295","phase":"","title":"An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA","status":"TERMINATED","sponsor":"Celltrion","startDate":"2013-12-17","conditions":"Rheumatoid Arthritis","enrollment":248},{"nctId":"NCT06601595","phase":"","title":"Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital","status":"NOT_YET_RECRUITING","sponsor":"Mohamed Nasr","startDate":"2024-10","conditions":"Inflammatory Bowel Disease (IBD), Spondylarthropathies, TNF-alpha Inhibitors","enrollment":100},{"nctId":"NCT05702879","phase":"","title":"Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success","status":"UNKNOWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-09-06","conditions":"Ulcerative Colitis","enrollment":240},{"nctId":"NCT03266471","phase":"","title":"Cytokines and Genes in Therapeutic Response in Crohn's Disease","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-10-13","conditions":"Inflammatory Bowel Diseases","enrollment":96},{"nctId":"NCT01219257","phase":"","title":"Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy","status":"COMPLETED","sponsor":"Diakonhjemmet Hospital","startDate":"2011-09","conditions":"Spondyloarthritis, Ultrasonography","enrollment":50},{"nctId":"NCT04115423","phase":"","title":"A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab","status":"UNKNOWN","sponsor":"Sungkyunkwan University","startDate":"2020-04-01","conditions":"Infection, Rheumatoid Arthritis","enrollment":9508},{"nctId":"NCT03640637","phase":"","title":"The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases","status":"UNKNOWN","sponsor":"Odense University Hospital","startDate":"2018-10-18","conditions":"Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis","enrollment":75},{"nctId":"NCT02434133","phase":"","title":"Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2015-04","conditions":"Inflammatory Bowel Disease (IBD)","enrollment":110},{"nctId":"NCT02116504","phase":"NA","title":"Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2014-04","conditions":"Rheumatoid Arthritis, Juvenile Idiopathic Arthritis","enrollment":156},{"nctId":"NCT02878161","phase":"PHASE4","title":"Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From \"Real World\"","status":"UNKNOWN","sponsor":"Fen Li","startDate":"2016-01","conditions":"Rheumatoid Arthritis","enrollment":240},{"nctId":"NCT01592292","phase":"","title":"An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-11","conditions":"Rheumatoid Arthritis","enrollment":90},{"nctId":"NCT02528292","phase":"","title":"Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Barts & The London NHS Trust","startDate":"2010-10","conditions":"Rheumatoid Arthritis","enrollment":24},{"nctId":"NCT00823641","phase":"PHASE2","title":"The HAM Infliximab Study","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2008-10","conditions":"HTLV-I-associated Myelopathy","enrollment":3},{"nctId":"NCT01361542","phase":"NA","title":"Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences","startDate":"2011-02","conditions":"Ankylosing Spondylitis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1625,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Anti TNF therapy including infliximab","genericName":"Anti TNF therapy including infliximab","companyName":"Janssen Biotech, Inc.","companyId":"janssen-biotech-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"Blocks tumor necrosis factor-alpha (TNF-alpha) by binding to it and preventing it from interacting with cell surface TNF receptors. Used for Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}